(Q37998436)

26 August 2017

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? (English)

1 reference

26 August 2017

David Paterson

7

0 references

Neil Woodford

series ordinal

8

object named as

Neil Woodford

1 reference

26 August 2017

1

David M Livermore

1 reference

26 August 2017

6

Yohei Doi

1 reference

26 August 2017

3

Peter M Hawkey

1 reference

26 August 2017

Jenny M Andrews

2

1 reference

26 August 2017

Pak-Leung Ho

series ordinal

4

1 reference

26 August 2017

Yoram Keness

series ordinal

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

29 March 2012

1 reference

Journal of Antimicrobial Chemotherapy

26 August 2017

1 reference

26 August 2017

67

1 reference

26 August 2017

7

1 reference

26 August 2017

1569-1577

1 reference

Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations.

26 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Determination of the in vivo pharmacodynamic profile of cefepime against extended-spectrum-beta-lactamase-producing Escherichia coli at various inocula

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Prevalence and clonality of extended-spectrum beta-lactamases in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

CTX-M: changing the face of ESBLs in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Extended-spectrum beta-lactamases in North America, 1987-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Carbapenem-resistant Klebsiella pnuemoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

bla(IMP-9) and its association with large plasmids carried by Pseudomonas aeruginosa isolates from the People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum, AmpC and metallo-beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKS088

21 January 2018

Identifiers

DOI

10.1093/JAC/DKS088

1 reference

26 August 2017

1 reference